Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation
Chemokine receptors and their ligands show dynamic variations after xenotransplantation that differ depending on the origin of the cell line.
»
02/22/14
SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin
E-cadherin loss promotes SNAI1 expression that controls the aggressiveness of PCA cells.
»
02/24/14
MicroRNA-26b suppresses the NF-kappaB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
miR-26b inhibited the expression of TAK1 and TAB3, two positive regulators of NF-kappaB pathway.
»
02/24/14
The case for mistletoe in the treatment of laryngeal cancer.
Benefit of mistletoe in laryngeal cancer treatment requires further investigation.
»
02/20/14
Targeting glutamine transport to suppress melanoma cell growth.
ASCT2-mediated glutamine transport is a potential therapeutic target for both BRAF(WT) and BRAF(V600E) melanoma.
»
08/06/13
The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.
Emerging evidence of Axl upregulation in numerous cancers.
»
02/12/13
Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability.
Nicotine activates its downstream signalling to interfere with the ubiquitination process and prevent Bcl-2 from being degraded.
»
10/21/13
IL-2 Enhances Cervical Cancer Cells Proliferation and JAK3/STAT5 Phosphorylation at Low Doses, While at High Doses IL-2 Has Opposite Effects.
At low doses of IL-2, the constitutive phosphorylation of JAK3 and STAT5 increases in the tumor cells.
»
02/20/14
β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression.
β-D-glucan increased RASSF1 expression in MCF-7 cells and IGFBP3, CTNNB1 and ERβ transcript expression.
»
11/22/13
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.
Non-evidence-based prescription of trastuzumab is associated with increased rates of CHF with no additional survival benefit.
»
12/17/13
< Prev
Next >